Clinical trial
Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
NCT00162565 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00162565 |
|---|---|
| Title | Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening |
| Official title | Beta-Blocker Continuation Versus Interruption in Patients With Congestive Heart Failure Hospitalized for Heart Failure Worsening (B-CONVINCED) |
| Acronym | BConvinced |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | beta-blocker treatment |
| Enrollment | 180 |
| Start date | Nov 1, 2004 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Sep 13, 2005 |
| Last update posted | May 25, 2009 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: